Characterization of deficit schizophrenia and reliability of the bidimensional model of its negative symptomatology

Nordic Journal of Psychiatry
Álvaro López-DíazMaría José Valdés-Florido

Abstract

Background: Cumulative evidence has demonstrated important differences between deficit (DS) and non-deficit (NDS) schizophrenia, suggesting that DS may be a separate disease. However, most data come from the same research groups and more replication is needed to validate this hypothesis.Aims: Our study aimed to examine the distribution of DS, to compare their characteristics with NDS patients and to analyze the reliability of the two-factor structure of its negative symptomatology in a Spanish clinical sample.Methods: Sixty clinically stabilized patients with schizophrenia were evaluated. The Schedule for the Deficit Syndrome was used for DS/NDS categorization. Patient characteristics included age, gender, education, age at onset of psychosis, duration of illness, family history of psychosis, type of antipsychotic regimen, schizophrenia subtype and severity of the disease.Results: DS prevalence was 28.3%. Bivariate analysis revealed statistical differences between DS and NDS in terms of years of education and schizophrenia subtype. Factor analysis replicated the two-factor solution consisting of the 'Expressive deficit' and 'Avolition-apathy' domains reported in previous studies.Conclusions: Our results were consistent with the...Continue Reading

References

Nov 1, 1989·Psychiatry Research·B KirkpatrickW T Carpenter
May 1, 1988·The American Journal of Psychiatry·W T CarpenterA M Wagman
Oct 1, 1994·The American Journal of Psychiatry·D I MayerhoffJ A Lieberman
Apr 1, 1993·Psychiatry Research·B KirkpatrickW T Carpenter
Mar 1, 1997·The American Journal of Psychiatry·R W BuchananW T Carpenter
Jun 1, 2000·The American Journal of Psychiatry·A KopelowiczJ Mintz
Feb 15, 2001·Archives of General Psychiatry·B KirkpatrickW T Carpenter
Mar 30, 2001·Schizophrenia Research·M A RoyC Mérette
May 18, 2001·Schizophrenia Research·C TekR W Buchanan
Mar 8, 2002·European Archives of Psychiatry and Clinical Neuroscience·R BottlenderH J Möller
Jun 26, 2003·The Journal of Clinical Psychiatry·Scott W Woods
Sep 25, 2003·European Archives of Psychiatry and Clinical Neuroscience·Ahmet TiryakiAhmet Göğüş
Sep 24, 2005·Schizophrenia Bulletin·David KimhyDolores Malaspina
Oct 29, 2005·Schizophrenia Bulletin·Jack J Blanchard, Alex S Cohen
Feb 17, 2006·Schizophrenia Bulletin·Brian KirkpatrickStephen R Marder
Jun 28, 2006·Molecular Psychiatry·A Jablensky
Jun 28, 2007·Medicina clínica·Miguel BernardoCelso Arango
Jan 22, 2008·Psychiatry Research·Makoto Nakaya, Kenichi Ohmori
Oct 7, 2008·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Brian Kirkpatrick, Silvana Galderisi
Feb 19, 2009·Schizophrenia Bulletin·Gregory P StraussJason Schwartz
Oct 21, 2009·European Archives of Psychiatry and Clinical Neuroscience·István SzendiZoltán Janka
Nov 6, 2009·Schizophrenia Research·Alex S CohenKyle S Minor
Apr 3, 2010·The American Journal of Psychiatry·David M GardnerRoss J Baldessarini
Apr 12, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Celso ArangoJavier Rejas
Aug 19, 2011·Psychopathology·Stefan KaiserJoe J Simon
Jun 1, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Silvana GalderisiUNKNOWN Eufest Study Group
Oct 16, 2012·Schizophrenia Research·Gregory P StraussBrian Kirkpatrick
Dec 12, 2012·Schizophrenia Research·Nobuhisa KanaharaMasaomi Iyo
Mar 12, 2013·Journal of Psychiatric Research·Edith LiemburgUNKNOWN Genetic Risk and Outcome of Psychosis (GROUP) Investigators
Jul 5, 2013·Indian Journal of Psychiatry·Vijay Danivas, Ganesan Venkatasubramanian
Nov 23, 2013·Comprehensive Psychiatry·Gábor CsuklyJános Réthelyi
Mar 29, 2014·Current Topics in Behavioral Neurosciences·Nash N BoutrosSilvana Galderisi
Nov 26, 2015·Neuropsychiatric Disease and Treatment·Yakup AlbayrakMurat Kuloglu
Mar 1, 2009·Multivariate Behavioral Research·J C F de WinterP A Wieringa
Jun 1, 2016·Schizophrenia Research·Armida MucciSilvana Galderisi
Jul 30, 2016·Psychological Medicine·V Peralta, M J Cuesta
Jan 28, 2017·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Stephen R Marder, Silvana Galderisi
Jun 3, 2017·Schizophrenia Bulletin·Brian KirkpatrickSilvana Galderisi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here